Brookdale Announces First Quarter 20...(penditures for the three months ended Ma...),Health

Three Months Ended March 31,

2008 2007

Type

Recurring $7,197 $6,225

Reimbursements (1,160) -

Net recurring 6,037 6,225

Corporate(1) 3,914 5,979

EBITDA-enhancing(2) 13,921 10,391

Development(3) 21,181 11,736

Net Total Capital Expenditures $45,053 $34,331

(1) Corporate primarily includes capital expenditures for information

technology systems and equipment.

(2) EBITDA-enhancing capital expenditures generally represent unusual or

non-recurring capital items and/or major renovations.

(3) Development capital expenditures primarily relate to the facility

expansion and de novo development program.

Our debt amortization for the three months ended March 31, 2008 and 2007 was as follows (in thousands):

Three Months Ended March 31,

2008 2007

Type

Scheduled Debt Amortization $391 $574

Lease Financing Debt Amortization -

FMV or no Purchase Option $1,625 $1,296

Lease Financing Debt Amortization -

Bargain Purchase Option 2,351 2,064

Total Debt Amortization $4,367 $3,934

Our ancillary services data for the last five quarters was as follows: